Search

M2 PRESSWIRE-January 8, 2025-: PH-ILD Treatment Market Size in the 7MM was ~USD 1,400 Million in 2023, is expected to increase by 2034 and estimated DelveInsight (C)1994-2025 M2 COMMUNICATIONS RDATE:07012025 [...]

M2 PRESSWIRE-December 6, 2024-: Idiopathic Pulmonary Fibrosis Therapeutics Market Size in the 7MM was ~USD 3,300 million in 2023, estimated DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:06122024 DelveInsight's 'Idiopathic Pulmonary Fibrosis Market [...]

M2 PRESSWIRE-November 7, 2024-: Pulmonary Hypertension associated with Interstitial Lung Disease Market Size in the 7MM was ~USD 1,400 million in 2023, estimated DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:06112024 DelveInsight's 'Pulmonary [...]

M2 PRESSWIRE-October 9, 2024-: Pulmonary Arterial Hypertension Treatment Market Size in the 7MM was ~USD 5000 Million in 2022, estimated DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:08102024 Pulmonary Arterial Hypertension Treatment Market [...]

M2 PRESSWIRE-September 26, 2024-: Idiopathic Pulmonary Fibrosis Treatment Market Size in the 7MM was ~USD 3,300 million in 2023, estimated DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:25092024 Idiopathic Pulmonary Fibrosis Treatment Market [...]

M2 PRESSWIRE-March 12, 2024-: Pulmonary Arterial Hypertension Market Expected to Experience Growth by 2032, Predicts DelveInsight | Merck, United Therapeutics, Respira Therapeutics, Gossamer Bio, Ferrer, AstraZeneca, Insmed (C)1994-2024 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-February 16, 2024-: PH-ILD Market Analysis 2032 Unveils Breakthrough Therapies and Regulatory Milestones from DelveInsight, Featuring Leading Innovators Insmed Incorporated, Bellerophon Therapeutics, United Therapeutics, (C)1994-2024 M2 COMMUNICATIONS RDATE:15022024 DelveInsight's [...]

M2 PRESSWIRE-February 14, 2024-: Progressive Fibrosing Interstitial Lung Disease Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2022-2032), Analyzes DelveInsight |Boehringer Ingelheim, FibroGen (C)1994-2024 M2 COMMUNICATIONS RDATE:13022024 [...]

M2 PRESSWIRE-January 17, 2024-: Idiopathic Pulmonary Fibrosis Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | United Therapeutics, Boehringer Ingelheim, Pliant Therapeutics (C)1994-2024 M2 COMMUNICATIONS RDATE:17012024 [...]

M2 PRESSWIRE-December 18, 2023-: Pulmonary Arterial Hypertension Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Merck Sharp & Dohme, Janssen Pharma, Actelion, Gossamer Bio (C)1994-2023 [...]

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's Sarcoidosis Market Insights report includes a comprehensive understanding of current treatment practices, sarcoidosis emerging drugs, market share [...]

(GlobeNewswire) - Idiopathic Pulmonary Fibrosis Market to Show Immense Growth at a CAGR of 6.6% During the Study Period (20192032) | DelveInsight The overall market of idiopathic pulmonary fibrosis is [...]

New York, USA, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Idiopathic Pulmonary Fibrosis Market to Show Immense Growth at a CAGR of 6.6% During the Study Period (2019-2032) | DelveInsight The [...]

M2 PRESSWIRE-October 18, 2023-: Pulmonary Arterial Hypertension Market to witness growth by 2032, estimates DelveInsight | Merck, United Therapeutics, Respira Therapeutics, Gossamer Bio, Ferrer, Liquidia Technologies, Tenax (C)1994-2023 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-September 22, 2023-: Pulmonary Hypertension Associated with Interstitial Lung Disease Market Size in the 7MM was approx. USD 1200 Million in 2022, estimates DelveInsight (C)1994-2023 M2 COMMUNICATIONS RDATE:21092023 The [...]

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's Hypertension Market Insights report includes a comprehensive understanding of current treatment practices, hypertension emerging drugs, market share [...]

According to DelveInsight, the hypertension market in the 7MM is expected to significantly change during the study period 2019--2032. While the hypertension market has generally shown a positive trend, certain [...]

M2 PRESSWIRE-June 27, 2023-: Pulmonary Sarcoidosis Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Eilly Lilly, Novartis, aTyr Pharma, Inc., Kinevant Sciences GmbH (C)1994-2023 [...]

M2 PRESSWIRE-June 26, 2023-: Pulmonary Hypertension Associated with Interstitial Lung Disease Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight (C)1994-2023 M2 COMMUNICATIONS RDATE:26062023 DelveInsight's 'Pulmonary [...]

M2 PRESSWIRE-June 13, 2023-: Pulmonary Arterial Hypertension Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Merck Inc., United Therapeutics, United Therapeutics, Aerovate (C)1994-2023 M2 COMMUNICATIONS [...]

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's 'Idiopathic Pulmonary Fibrosis Pipeline Insight - 2023' report provides comprehensive global coverage of pipeline idiopathic pulmonary fibrosis [...]

The prevalence of idiopathic pulmonary fibrosis has been rising over the past few years, which prompts the growing demand for treatment options. The increasing prevalence of idiopathic pulmonary fibrosis and [...]

M2 PRESSWIRE-May 24, 2023-: Interstitial Lung Diseases Pipeline Insight | Key Companies - Roche, Bayer, Insmed, Avalyn Pharma, PureTech Health, Novartis, Horizon, MediciNova, Endeavor BioMedicines, Pliant Therapeutics, and Others (C)1994-2023 [...]

M2 PRESSWIRE-May 12, 2023-: Chronic Pulmonary Hypertension Market and Epidemiology 2032: Treatment market, Therapies, FDA Approvals, Companies and Patient Population by DelveInsight (C)1994-2023 M2 COMMUNICATIONS RDATE:11052023 (Albany, USA) DelveInsight's 'Chronic [...]

M2 PRESSWIRE-May 10, 2023-: Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight (C)1994-2023 [...]

M2 PRESSWIRE-April 12, 2023-: 80+ Active Companies working to develop 80+ Pipeline Therapies for Idiopathic Pulmonary Fibrosis Treatment Landscape | Major Companies - Roche, Novartis, Vicore Pharma, and Others. (C)1994-2023 [...]

M2 PRESSWIRE-March 22, 2023-: Pulmonary Arterial Hypertension Pipeline Assets Segmented by Stage, Product Type, Route of Administration and Molecule Type (C)1994-2023 M2 COMMUNICATIONS RDATE:21032023 DelveInsight's, 'Pulmonary Arterial Hypertension Pipeline Insight, [...]

M2 PRESSWIRE-March 22, 2023-: Interstitial Lung Disease Pipeline Assets Segmented by Stage, Product Type, Route of Administration and Molecule Type (C)1994-2023 M2 COMMUNICATIONS RDATE:21032023 DelveInsight's, 'Interstitial Lung Diseases Pipeline Insight, [...]

M2 PRESSWIRE-February 23, 2023-: Pulmonary Hypertension Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market (C)1994-2023 M2 COMMUNICATIONS RDATE:22022023 DelveInsight's 'Pulmonary Hypertension Market Insights, Epidemiology, and [...]

M2 PRESSWIRE-January 26, 2023-: Idiopathic Pulmonary Fibrosis Pipeline Appears Robust with 80+ Key Pharma Companies Actively Working in the Space (C)1994-2023 M2 COMMUNICATIONS RDATE:25012023 DelveInsight's, 'Idiopathic Pulmonary Fibrosis Pipeline Insight, [...]

M2 PRESSWIRE-January 23, 2023-: Chronic Pulmonary Hypertension Market is Expected to Expand at a Healthy Growth Rate by (2022-2032), States DelveInsight | Key Companies - Attgeno AB, Cereno Scientific AB, [...]

M2 PRESSWIRE-January 19, 2023-: Idiopathic Pulmonary Fibrosis Market is Expected to Expand at a Healthy Growth Rate by (2022-2032), States DelveInsight | Key Companies - FibroGen, Hoffmann-La Roche Ltd., United [...]

M2 PRESSWIRE-January 17, 2023-: Interstitial Lung Disease Pipeline Insight Report | 120+ Companies and 120+ Drugs (C)1994-2023 M2 COMMUNICATIONS RDATE:16012023 DelveInsight's, 'Interstitial Lung Diseases Pipeline Insight 2023' report provides comprehensive [...]

M2 PRESSWIRE-October 11, 2022-: Progressive Fibrosing Interstitial Lung Disease Market to Observe Impressive Growth by (2022-2032), Evaluates DelveInsight | Key Companies - Boehringer Ingelheim, FibroGen, Bristol-Myers Squibb (C)1994-2022 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-October 10, 2022-: Chronic Pulmonary Hypertension Market Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market (C)1994-2022 M2 COMMUNICATIONS RDATE:08102022 DelveInsight's 'Chronic Pulmonary Hypertension Market Insights, [...]

LAS VEGAS: DelveInsight Business Research LLP has issued the following news release: DelveInsight's Pulmonary Arterial Hypertension Market Insights report includes a comprehensive understanding of current treatment practices, pulmonary arterial hypertension [...]

The expected launch of drugs by the leading players such as Acceleron Pharma Inc., United Therapeutics, Altavant Sciences, Aerovate Therapeutics, Respira Therapeutics, and others in the pipeline shall fuel the [...]

M2 PRESSWIRE-September 16, 2022-: According to DelveInsight, the Pulmonary Arterial Hypertension Market in 7MM is expected to witness a major change in the study period 2019-2032 (C)1994-2022 M2 COMMUNICATIONS RDATE:15092022 [...]

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's Progressive Fibrosing Interstitial Lung Disease Market Insights report includes a comprehensive understanding of current treatment practices, progressive [...]

The progressive fibrosing interstitial lung disease market is anticipated to increase due to factors such as increased awareness of PF-ILD along with the expected launch of emerging therapies during the [...]

M2 PRESSWIRE-September 1, 2022-: Systemic Sclerosis Market is Projected to Boost at a Moderate Growth Rate by 2032 - DelveInsight | Key Companies - Gesynta Pharma AB, Active Biotech AB, [...]

M2 PRESSWIRE-July 5, 2022-: Emphysema Market Size, Share, Epidemiology, Trends Analysis, Therapeutics Pipeline Outlook, and Insights 2032 | Key Companies - United Therapeutics, Mereo BioPharma, GlaxoSmithKline, and Others (C)1994-2022 M2 [...]

M2 PRESSWIRE-May 3, 2022-: Chronic Pulmonary Hypertension Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working | Delveinsight (C)1994-2022 M2 COMMUNICATIONS RDATE:02052022 DelveInsight's 'Chronic Pulmonary Hypertension Market Insights, Epidemiology, [...]

M2 PRESSWIRE-April 26, 2022-: Emphysema Market Size, Share and Trends Analysis, Therapeutics Pipeline Outlook, and Epidemiology Insights 2032 | Key Companies - Mereo BioPharma, GlaxoSmithKline, United Therapeutics, and Others (C)1994-2022 [...]

New York: ReportLinker has issued the following news release: Reportlinker.com announces the release of the report 'Pulmonary Arterial Hypertension Market Size, Share & Trends Analysis Report By Drug Class, By [...]

New York, Feb 04, 2022 (GLOBE NEWSWIRE via COMTEX) -- Reportlinker.com announces the release of the report 'Pulmonary Arterial Hypertension Market Size, Share & Trends Analysis Report By Drug Class, [...]

(GlobeNewswire) - According to latest report Pulmonary Arterial Hypertension Market by Drug Class (Prostacyclin And Prostacyclin Analogs, Soluble Guanylate Cyclase (SGC) Stimulators, Endothelin Receptor Antagonist (ERA), Phosphodiesterase 5 (PDE-5), Vasodilators), [...]

(GlobeNewswire) - According to latest report Pulmonary Arterial Hypertension Market by Drug Class (Prostacyclin And Prostacyclin Analogs, Soluble Guanylate Cyclase (SGC) Stimulators, Endothelin Receptor Antagonist (ERA), Phosphodiesterase 5 (PDE-5), Vasodilators), [...]

M2 PRESSWIRE-July 19, 2021-: Pulmonary Arterial Hypertension (PAH) Clinical and Commercial Assessment of the Pipeline Therapies, Market Trends, Leading Companies, Emerging Drugs, and Epidemiology Forecast (C)1994-2021 M2 COMMUNICATIONS RDATE:16072021 DelveInsight's [...]

DUBLIN, June 10, 2021 /PRNewswire/ -- The 'Pulmonary Arterial Hypertension Market and Forecast Analysis to 2025' drug pipelines has been added toResearchAndMarkets.com's offering. The report estimates that in 2018, there [...]